Skip to content
Clinical Trials – home
The NetherlandsBack to the Netherlands

Clinical trials in Almelo – page 5

61 clinical trials in Almelo, The Netherlands across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

The NetherlandsOur site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)
Almelo at a glance
61
clinical trials
  • Paediatric trials0
  • Research sites2
Type of trial
Recruitment status
Quick filters

61 trials in Almelo

Open in trial search

Diabetic nephropathy+2

Not recruiting

Remote Study on Empagliflozin and Finerenone for Reducing Kidney Issues in Type 2 Diabetes Patients

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Empagliflozin
  • Sponsor:Universitair Medisch Centrum Groningen

Study on Reducing Protein in Urine for Patients with Chronic Kidney Disease Using Finerenone and Semaglutide

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Finerenone
  • Sponsor:Universitair Medisch Centrum Groningen

Study on TAR-200 and Cetrelimab for Patients with Muscle-Invasive Bladder Cancer Ineligible for or Refusing Platinum-Based Chemotherapy

InvestigationalNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Cetrelimab
  • Sponsor:Janssen Cilag International

Study on the Effectiveness of Enlicitide Chloride in Reducing Cardiovascular Events in Patients with Atherosclerotic Cardiovascular Disease

Investigational
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Sponsor:Merck Sharp & Dohme LLC
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Secukinumab
  • Sponsor:Novartis Pharma AG

Study on the Effectiveness of Paclitaxel, Docetaxel, and Oxaliplatin in Patients with Resectable Gastric Cancer

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting

Study on Bintrafusp Alfa with Chemoradiation for Patients with Esophageal Squamous Cell Carcinoma

InvestigationalNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Bintrafusp Alfa
  • Sponsor:Amsterdam UMC Stichting

Study of Pembrolizumab and Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer

Registered drug
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Enzalutamide
  • Sponsor:Merck Sharp & Dohme LLC

Colon cancer stage III+1

Not recruiting

Study on Aspirin for Preventing Recurrence and Improving Survival in Patients with Stage II and III Colon Cancer

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Leiden University Medical Center
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Prednisone
  • Sponsor:Novartis Pharma AG

Study on Milvexian and Drug Combination for Patients Recovering from a Heart Attack

Registered drug
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Janssen Cilag International

Study Comparing Docetaxel Alone and Docetaxel with Radium-223 for Patients with Metastatic Castration-Resistant Prostate Cancer

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Radium RA 223 dichloride
  • Sponsor:Memorial Sloan Kettering Cancer Center

Other cities in the Netherlands

The busiest research cities in the country

All 103 cities in the Netherlands

Clinical research in Almelo

What the registry says about research in the country

01 Oncology Research

Innovative clinical trials focusing on advanced gastric cancer, prostate cancer, and breast cancer treatments. Studies include evaluation of new imaging techniques and therapeutic approaches for better disease management.

  • Gastric cancer staging and treatment
  • Prostate cancer diagnostics
  • HER2-positive breast cancer therapy

Research includes novel approaches to peritoneal dissemination and esophageal cancer treatment protocols.

02 Cardiovascular Studies

Comprehensive research into heart failure prevention and cardiovascular disease management, with emphasis on innovative drug combinations and preventive strategies.

  • Heart failure risk reduction
  • Atherosclerotic disease management
  • Post-surgical cardiac complications

Trials focus on both preventive measures and treatment optimization for various cardiac conditions.

03 Renal and Metabolic Disorders

Studies examining treatments for chronic kidney disease and type 2 diabetes, with particular focus on innovative therapeutic combinations and personalized treatment approaches.

  • Albuminuria management
  • Diabetic kidney disease
  • Treatment optimization strategies

Research emphasizes remote trial methodologies and personalized treatment protocols.

04 Hematology Research

Advanced studies in multiple myeloma and lymphoma treatments, exploring new therapeutic approaches and treatment-free intervals.

  • Multiple myeloma therapy
  • Non-Hodgkin lymphoma treatment
  • Targeted anti-cancer approaches

Focus on developing personalized treatment strategies and improving patient outcomes.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.